Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ALG2 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | MYB | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-06 |
mRNA | RPL14 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
mRNA | ADGRG5 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | ANKRD55 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | EPB42 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | MATK | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | CLEC5A | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | NKX3-2 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | NFE2 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |